The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer (NCT02364557).
 
Steven J. Chmura
No Relationships to Disclose
 
Kathryn A. Winter
No Relationships to Disclose
 
Hania A Al-Hallaq
No Relationships to Disclose
 
Virginia F. Borges
Research Funding - Abbott/AbbVie (Inst); Advaxis (Inst); Galena Biopharma (Inst); Incyte (Inst); Merrimack (Inst); Oncothyreon (Inst)
 
Nora T. Jaskowiak
No Relationships to Disclose
 
Martha Matuszak
No Relationships to Disclose
 
Michael T. Milano
No Relationships to Disclose
 
Joseph Kamel Salama
Honoraria - Reflexion Medical
Consulting or Advisory Role - Bristol-Myers Squibb (I); Merck (I)
Speakers' Bureau - Bristol-Myers Squibb (I)
Research Funding - AbbVie; Bristol-Myers Squibb (I); Celldex (I); Dynavax Technologies (I); Genentech/Roche (I); Immunocore (I); Merck (I); Reata Pharmaceuticals (I)
 
Wendy A. Woodward
No Relationships to Disclose
 
Julia R. White
Honoraria - Qfix
Research Funding - Intraop Medical (Inst)
Travel, Accommodations, Expenses - IBA; Qfix